Inovalon Holdings, Inc. - (INOV): Price and Financial Metrics


Inovalon Holdings, Inc. - (INOV)

Today's Latest Price: $25.36 USD

0.07 (0.28%)

Updated Aug 7 12:00am

Add INOV to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 68 in Medical - Services

See all "A" rated Strong Buy stocks

INOV Stock Summary

  • With a one year PEG ratio of 811.36, Inovalon Holdings Inc is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than 95.32% of US stocks.
  • With a price/earnings ratio of 343.33, Inovalon Holdings Inc P/E ratio is greater than that of about 97.9% of stocks in our set with positive earnings.
  • Price to trailing twelve month operating cash flow for INOV is currently 30.38, higher than 86.81% of US stocks with positive operating cash flow.
  • If you're looking for stocks that are quantitatively similar to Inovalon Holdings Inc, a group of peers worth examining would be CE, CUB, CCMP, CLGX, and CAMP.
  • INOV's SEC filings can be seen here. And to visit Inovalon Holdings Inc's official web site, go to www.inovalon.com.
INOV Daily Price Range
INOV 52-Week Price Range

INOV Stock Price Chart Technical Analysis Charts


INOV Price/Volume Stats

Current price $25.36 52-week high $25.71
Prev. close $25.29 52-week low $13.39
Day low $24.80 Volume 523,600
Day high $25.48 Avg. volume 509,220
50-day MA $20.24 Dividend yield N/A
200-day MA $18.49 Market Cap 3.94B

Inovalon Holdings, Inc. - (INOV) Company Bio


Inovalon Holdings provides advanced cloud-based data analytics and data-driven intervention platforms to the healthcare industry in the United States. The company was founded in 1998 and is based in Bowie, Maryland.

INOV Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$25.36$2.86 -89%

Below please find a table outlining a discounted cash flow forecast for INOV, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that Inovalon Holdings Inc ranked in the 13th percentile in terms of potential gain offered. We should note, though, that all scenearios modelled for this stock suggest it is overvalued. The most interesting components of our discounted cash flow analysis for Inovalon Holdings Inc ended up being:

  • In the past 5.33 years, Inovalon Holdings Inc has a compound free cash flow growth rate of -0.01%; that's higher than merely 21.08% of free cash flow generating stocks in the Technology sector.
  • Inovalon Holdings Inc's weighted average cost of capital (WACC) is 9%; for context, that number is higher than 67.15% of tickers in our DCF set.
  • Inovalon Holdings Inc's effective tax rate, as measured by taxes paid relative to net income, is at 0 -- greater than just 0% of US stocks with positive free cash flow.


Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price
0%-89%
1%-89%
2%-89%
3%-89%
4%-88%
5%-88%

For other companies in the Technology that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as INOV, try FEYE, HPE, SIMO, SPOT, and GRUB.





INOV Latest News Stream


Event/Time News Detail
Loading, please wait...

INOV Latest Social Stream


Loading social stream, please wait...

View Full INOV Social Stream

Latest INOV News From Around the Web

Below are the latest news stories about Inovalon Holdings Inc that investors may wish to consider to help them evaluate INOV as an investment opportunity.

Inovalon Holdings, Inc. 2020 Q2 - Results - Earnings Call Presentation

The following slide deck was published by Inovalon Holdings, Inc. in conjunction with their 2020 Q2 earnings call....

SA Transcripts on Seeking Alpha | July 30, 2020

Inovalon Holdings (INOV) Q2 Earnings and Revenues Beat Estimates

Inovalon Holdings (INOV) delivered earnings and revenue surprises of 36.36% and 1.81%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

Yahoo | July 29, 2020

Inovalon Reports Second Quarter 2020 Results

Second Quarter 2020 Highlights * Q2 revenue of $162.2 million, up 3% YoY * Q2 subscription-based platform revenue of $142.1 million, up 13% YoY, equating to 88% of Q2 total revenue * Q2 net income of $2.0 million, resulting in diluted net income of $0.01 per share * Q2 Non-GAAP net income of $22.0 million, up 15% YoY, resulting in Non-GAAP net income of $0.15 per share * Q2 Adjusted EBITDA of $56.6 million, up 8% YoY, resulting in Adjusted EBITDA margin of 34.9% * Q2 net cash provided by operating activities of $49.0 million * Q2 new sales Annual Contract Value (ACV)1 totaled a record $75.7 million, up 38.1% YoYDebt & Cash Highlights * Voluntarily repaid $99 million (100% of all outstanding amounts) of revolver on June 4, 2020 * Cash balance as of June 30, 2020 totaling $95.6...

Yahoo | July 29, 2020

Should Inovalon Holdings, Inc. (NASDAQ:INOV) Focus On Improving This Fundamental Metric?

While some investors are already well versed in financial metrics (hat tip), this article is for those who would like...

Yahoo | July 23, 2020

Inovalon ONE® Platform Selected by Walmart

Retailer’s Specialty Pharmacy Business to Implement ScriptMed® Cloud Solution to Empower Enhanced Outcomes and Economics for its CustomersBOWIE, Md., July 23, 2020 (GLOBE NEWSWIRE) -- Inovalon (Nasdaq: INOV), a leading provider of cloud-based platforms empowering data-driven healthcare, today announced a long-term engagement with Walmart’s Specialty Pharmacy business (NYSE: WMT) to provide cloud-based capabilities through the Inovalon ONE® Platform as part of its data-driven strategy to improve outcomes and economics for its customers. The high-complexity and high-cost nature of specialty pharmacy stands to benefit significantly from the capabilities enabled through the Inovalon ONE® Platform. Through the implementation of ScriptMed® Cloud, a software-as-a-service (SaaS) cloud offering...

Yahoo | July 23, 2020

Read More 'INOV' Stories Here

INOV Price Returns

1-mo 33.76%
3-mo 51.40%
6-mo 18.67%
1-year 52.31%
3-year 93.59%
5-year 18.06%
YTD 34.75%
2019 32.72%
2018 -5.47%
2017 45.63%
2016 -39.41%
2015 N/A

Continue Researching INOV

Want to see what other sources are saying about Inovalon Holdings Inc's financials and stock price? Try the links below:

Inovalon Holdings Inc (INOV) Stock Price | Nasdaq
Inovalon Holdings Inc (INOV) Stock Quote, History and News - Yahoo Finance
Inovalon Holdings Inc (INOV) Stock Price and Basic Information | MarketWatch


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 1.0724 seconds.